Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.02.2021 | Case report

Antineoplastics

Chronic myeloid leukaemia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Funakoshi S, et al. Incidence of Secondary Malignancy of Chronic Myeloid Leukemia during Treatment of Breast Cancer with Hormone Therapy. Gan to Kagaku Ryoho 48: 73-75, No. 1, Jan 2021. Available from: URL: https://pubmed.ncbi.nlm.nih.gov/33468727/ [Japanese; summarised from a translation] Funakoshi S, et al. Incidence of Secondary Malignancy of Chronic Myeloid Leukemia during Treatment of Breast Cancer with Hormone Therapy. Gan to Kagaku Ryoho 48: 73-75, No. 1, Jan 2021. Available from: URL: https://​pubmed.​ncbi.​nlm.​nih.​gov/​33468727/​ [Japanese; summarised from a translation]
Metadaten
Titel
Antineoplastics
Chronic myeloid leukaemia: case report
Publikationsdatum
01.02.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-91143-3

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Antibacterials

Case report

Almotriptan

Case report

Antineoplastics

Case report

Multiple drugs